An intralesional injection of mesenchymal stem cells can significantly increase remission rates in patients with complex perianal fistulas associated with Crohn’s disease, an experimental study shows. According to the authors of the Phase 3 randomised double-blind placebo controlled trial of 212 adults across 49 hospitals and seven countries in Europe and Israel their findings suggest that ...
More evidence for stem cells in refractory fistulising Crohn’s disease
By Mardi Chapman
29 Sep 2016